Tenon Medical Raises $3 Million in Private Placement

The offering, finalized on August 27, 2026, sets a combined effective price of $5.02 per share and accompanying warrants. Investors also have the option of pre-funded warrants priced at $5.019. These warrants carry an exercise price of $5.02 and are set to expire five years from the date of issuance, while pre-funded warrants feature an exercise price of $0.001 per share.

WallachBeth Capital served as the sole placement agent for the transaction, which is being conducted under Section 4(a)(2) of the Securities Act of 1933 and Regulation D. Because these securities are not registered, Tenon Medical has committed to providing customary registration rights for the common stock and the shares underlying the various warrants. The company intends to close the deal pending the satisfaction of standard closing conditions.